Investor · Waltham, MA
James F. Oliviero, Iii
Open James in the network graph →Active
Dec 2021
to Dec 2025
Most-connected co-filers (69)
Lindsay A. Rosenwald · New York, NY11 sharedKeith N. Nilsson · Menlo Park, CA8 sharedJonathan N. Mcqueen · Menlo Park, CA6 sharedJeremiah Brewer · Los Angeles, CA6 sharedLarry N. Feinberg · GREENWICH, CT5 sharedBryan A. Helmkamp · New York, NY5 sharedBarry F. Salzman · Waltham, MA5 sharedMatthew L. Lipscomb · Boulder, CO5 sharedDoug D. Cameron · Boulder, CO5 sharedJosko D. Bobanovic · Boulder, CO5 sharedDarell Krasnoff · Los Angeles, CA5 sharedMuhan Zou · New York, NY5 sharedAndrew M. Peltz · Beverly Hills, CA5 sharedKelly Watters · Telluride, CO5 sharedZhong Shao · New York, NY5 sharedAlastair D. Cooper · Boulder, CO5 sharedMichael S. Weiss · New York, NY5 sharedRob D. Van Der Meij · Boulder, CO5 sharedHarlan M. Peltz · Los Angeles, CA5 sharedNeil A. Herskowitz · New York, NY5 sharedJoseph G. Machado · Boston, MA5 sharedAkihiro C. Ko · Baltimore, MD4 sharedHiroaki C. Kobayashi · Baltimore, MD4 sharedGarrett F. Gray · Waltham, MA4 shared Recent filings (18)
DMC Biotechnologies, Inc.Dec 2025 · 23 co-filers$1.7MDMC Biotechnologies, Inc.Dec 2025 · 23 co-filers$2.5MXplorer Capital Growth I, LLCJun 2025 · 7 co-filersDMC Biotechnologies, Inc.Apr 2025 · 23 co-filers$10.0MCheckpoint Therapeutics, Inc.Jul 2024 · 22 co-filersXplorer Capital Fund V, L.P.May 2024 · 7 co-filersXplorer Capital Growth I, LLCApr 2024 · 7 co-filers$10.0MCheckpoint Therapeutics, Inc.Feb 2024 · 20 co-filersXplorer Capital continuation Fund I, LLCDec 2023 · 5 co-filersXC Fiscal Note - C, LLCDec 2023 · 5 co-filers$905KXplorer Capital Fund V, L.P.Apr 2023 · 7 co-filersCheckpoint Therapeutics, Inc.Apr 2023 · 23 co-filersCheckpoint Therapeutics, Inc.Mar 2023 · 23 co-filersXplorer Capital Growth I, LLCNov 2022 · 7 co-filersDMC Biotechnologies, Inc.Aug 2022 · 22 co-filers$67KXplorer Capital Growth I, LLCDec 2021 · 7 co-filersDMC Biotechnologies, Inc.Dec 2021 · 20 co-filers$43.5MCheckpoint Therapeutics, Inc.Sep 2016 · 17 co-filers$62.5MCheckpoint Therapeutics, Inc.Sep 2016 · 17 co-filers$62.5M Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See James in the interactive graph →